RAD) RxSheets.com to Partner With PCS Health Systems to Jointly Market PerformanceScript Program
OAK BROOK, Ill., Apr 18, 2000 (BUSINESS WIRE) -- RxSheets.com, a wholly owned
subsidiary of MedCare Technologies, Inc. (NASDAQ: MCAR) announced today that it
will offer the PCS Health Systems PerformanceScript(R)program on its Web site
(www.RxSheets.com), making it available to thousands of physicians nationwide.
PCS is one of the country's largest pharmacy benefit managers and a wholly owned
subsidiary of Rite Aid Corporation (NYSE, PSE: RAD).
PerformanceScript(R) is an alternative to conventional drug sampling programs
that offer improved health safeguards and better monitoring of patients starting
new drug therapy. The innovative program offers a substantial improvement over
packaged samples that physicians conventionally have distributed to patients.
With PerformanceScript, physicians provide patients with a card and prescription
for the medication available through the PCS program. Patients then redeem the
prescription at a pharmacy for a free trial supply of the medication. Included
with the card is information to help patients understand the medication and the
condition for which the drug has been prescribed.
Physicians who are interested in obtaining a supply of PerformanceScript cards
for various pharmaceutical products may do so by ordering them through
RxSheets.com.
"A physician's prescribed regimen is more likely to be followed when patients
understand their medical condition and the prescribed treatment," said Marsha C.
Moore, M.D., PCS' chief medical officer. "By including the educational component
in our PerformanceScript program, we hope to empower patients to take a greater
role in their own health care."
PerformanceScript also provides an important safeguard for patients, which is
unavailable through traditional sampling methods that bypass the normal checks
and balances conducted by a pharmacist. By requiring the patient to present the
prescription at a pharmacy, the program affords the pharmacist the opportunity
to counsel patients on their conditions and medication at the time patients
first start a new drug regimen. It also allows the pharmacist to determine if
the drug might interact negatively with another drug the patient is currently
taking or if some other potential problem exists. In addition to protecting the
patient, this also can save costs for the patient's health plan.
The program also eliminates the need for physicians, to store, safeguard and
monitor prescription samples. In addition, it saves the physician from having to
waste and discard samples that expire before they are used.
PerformanceScript enhances pharmaceutical companies' current sampling promotions
and also provides access to drugs that do not have traditional sampling
programs. By making PerformanceScript available to physicians on its Web site,
RxSheets.com will offer an alternative way for pharmaceutical companies to
provide a starter supply of medication to patients through their doctors.
"We believe that by partnering with PCS, an innovator in health care management,
we can offer viable solutions and alternatives to the pharmaceutical and
physician community," said Jeff Aronin, President and Chief Executive Officer of
MedCare Technologies.
PCS Health Systems, Inc. (www.pcshs.com)is one of the nation's largest pharmacy
benefit managers, providing drug and health management solutions for health
plans and patients. As America's premier pharmaceutical care system, PCS works
to encourage proper drug use and helps to lower the cost of drugs for its
clients. PCS manages and monitors 300 million individual prescriptions each year
representing $12 billion in drug expenditures.
RxSheets.com (www.rxsheets.com) is a business-to-business web site for
physicians and pharmaceutical companies. Pharmaceutical companies spend over $17
billion per year on traditional sales tactics, such as personal visits to
physicians' offices to drop off sample products. RxSheets.com offers
pharmaceutical companies a cost-effective way to present their product samples
to the widest possible audience of physicians, ultimately increasing their
bottom line. On the flip side, RxSheets.com offers physicians a central location
to sample an unlimited number of product samples, saving time and presenting
them with new products and services to treat patients. In addition to product
samples, RxSheets.com offers a wide array of useful information and other
features designed specifically for pharmaceutical companies.
MedCare Technologies, Inc. is a healthcare technology service company that
focuses on under-served high growth markets. The Company began by developing the
MedCare Program, now the nation's leading conservative therapy for treating
urinary incontinence, a hidden health condition that, at approximately $26
billion, costs more than diabetes and bypass surgery combined.
This news release contains forward-looking statements as defined by the Private
Securities Litigation Reform Act of 1995. Forward-looking statements include
statements concerning plans, objectives, goals, strategies, future events or
performance and underlying assumptions and other statements, which are other
than statements of historical facts. These statements are subject to
uncertainties and risks including, but not limited to, product and service
demand and acceptance, changes in technology, changes in insurance
reimbursement, economic conditions, the impact of competition and pricing,
government regulation, and other risks defined in this document and in
statements filed from time to time with the Securities and Exchange Commission.
All such forward-looking statements, whether written or oral, and whether made
by or on behalf of the Company are expressly qualified by these cautionary
statements and any other cautionary statements which may accompany the
forward-looking statements. In addition, the Company disclaims any obligation to
update any forward-looking statements to reflect events or circumstances after
the date hereof.
Investor Awareness, Inc. is not a brokerage firm or securities dealer, so this
is not a solicitation to buy or sell securities, and does not purport to be a
complete analysis of MedCare Technologies, Inc. (NASDAQ: MCAR). The material
herein was provided by MedCare Technologies, Inc. and is for informational
purposes only. Investment in the Company's securities involves a high degree of
risk and should not be considered without first reading its most recent
financial statements. Investor Awareness, Inc. receives a fee from MedCare
Technologies, Inc for marketing services and its owners/employees may from time
to time purchase, sell, or have a position in the securities of MedCare
Technologies, Inc.
For more information contact Investor Awareness, Inc. at 847-945-2222 or visit
www.investorawareness.com or www.medcareonline.com. |
